Request for Covid-19 Impact Assessment of this Report
The United States Pet Meds and Supplements market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pet Meds and Supplements market, reaching US$ million by the year 2028. As for the Europe Pet Meds and Supplements landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Pet Meds and Supplements players cover Boehringer Ingelheim, Ceva Sante Animale, Bimeda Animal Health, and Dechra Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pet Meds and Supplements market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
External Use
Oral Use
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Dogs
Cats
Rabbit
Bird
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boehringer Ingelheim
Ceva Sante Animale
Bimeda Animal Health
Dechra Pharmaceuticals
Zoetis
Merck
Elanco
Bayer
Boehringer
Novartis
Virbac
Ceva
Vetoquinol
Nexvet
Aratana Therapeutics
Kindred Biosciences
Ambrx
Entest Biomedical
Taconic Biosciences
Dechra Veterinary Products
Ouro Fino Saude
Norbrook
Frontline
Zesty Paws
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pet Meds and Supplements Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pet Meds and Supplements by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pet Meds and Supplements by Country/Region, 2017, 2022 & 2028
2.2 Pet Meds and Supplements Segment by Type
2.2.1 External Use
2.2.2 Oral Use
2.3 Pet Meds and Supplements Sales by Type
2.3.1 Global Pet Meds and Supplements Sales Market Share by Type (2017-2022)
2.3.2 Global Pet Meds and Supplements Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pet Meds and Supplements Sale Price by Type (2017-2022)
2.4 Pet Meds and Supplements Segment by Application
2.4.1 Dogs
2.4.2 Cats
2.4.3 Rabbit
2.4.4 Bird
2.4.5 Other
2.5 Pet Meds and Supplements Sales by Application
2.5.1 Global Pet Meds and Supplements Sale Market Share by Application (2017-2022)
2.5.2 Global Pet Meds and Supplements Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pet Meds and Supplements Sale Price by Application (2017-2022)
3 Global Pet Meds and Supplements by Company
3.1 Global Pet Meds and Supplements Breakdown Data by Company
3.1.1 Global Pet Meds and Supplements Annual Sales by Company (2020-2022)
3.1.2 Global Pet Meds and Supplements Sales Market Share by Company (2020-2022)
3.2 Global Pet Meds and Supplements Annual Revenue by Company (2020-2022)
3.2.1 Global Pet Meds and Supplements Revenue by Company (2020-2022)
3.2.2 Global Pet Meds and Supplements Revenue Market Share by Company (2020-2022)
3.3 Global Pet Meds and Supplements Sale Price by Company
3.4 Key Manufacturers Pet Meds and Supplements Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pet Meds and Supplements Product Location Distribution
3.4.2 Players Pet Meds and Supplements Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pet Meds and Supplements by Geographic Region
4.1 World Historic Pet Meds and Supplements Market Size by Geographic Region (2017-2022)
4.1.1 Global Pet Meds and Supplements Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pet Meds and Supplements Annual Revenue by Geographic Region
4.2 World Historic Pet Meds and Supplements Market Size by Country/Region (2017-2022)
4.2.1 Global Pet Meds and Supplements Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pet Meds and Supplements Annual Revenue by Country/Region
4.3 Americas Pet Meds and Supplements Sales Growth
4.4 APAC Pet Meds and Supplements Sales Growth
4.5 Europe Pet Meds and Supplements Sales Growth
4.6 Middle East & Africa Pet Meds and Supplements Sales Growth
5 Americas
5.1 Americas Pet Meds and Supplements Sales by Country
5.1.1 Americas Pet Meds and Supplements Sales by Country (2017-2022)
5.1.2 Americas Pet Meds and Supplements Revenue by Country (2017-2022)
5.2 Americas Pet Meds and Supplements Sales by Type
5.3 Americas Pet Meds and Supplements Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pet Meds and Supplements Sales by Region
6.1.1 APAC Pet Meds and Supplements Sales by Region (2017-2022)
6.1.2 APAC Pet Meds and Supplements Revenue by Region (2017-2022)
6.2 APAC Pet Meds and Supplements Sales by Type
6.3 APAC Pet Meds and Supplements Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pet Meds and Supplements by Country
7.1.1 Europe Pet Meds and Supplements Sales by Country (2017-2022)
7.1.2 Europe Pet Meds and Supplements Revenue by Country (2017-2022)
7.2 Europe Pet Meds and Supplements Sales by Type
7.3 Europe Pet Meds and Supplements Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pet Meds and Supplements by Country
8.1.1 Middle East & Africa Pet Meds and Supplements Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pet Meds and Supplements Revenue by Country (2017-2022)
8.2 Middle East & Africa Pet Meds and Supplements Sales by Type
8.3 Middle East & Africa Pet Meds and Supplements Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pet Meds and Supplements
10.3 Manufacturing Process Analysis of Pet Meds and Supplements
10.4 Industry Chain Structure of Pet Meds and Supplements
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pet Meds and Supplements Distributors
11.3 Pet Meds and Supplements Customer
12 World Forecast Review for Pet Meds and Supplements by Geographic Region
12.1 Global Pet Meds and Supplements Market Size Forecast by Region
12.1.1 Global Pet Meds and Supplements Forecast by Region (2023-2028)
12.1.2 Global Pet Meds and Supplements Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pet Meds and Supplements Forecast by Type
12.7 Global Pet Meds and Supplements Forecast by Application
13 Key Players Analysis
13.1 Boehringer Ingelheim
13.1.1 Boehringer Ingelheim Company Information
13.1.2 Boehringer Ingelheim Pet Meds and Supplements Product Offered
13.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Boehringer Ingelheim Main Business Overview
13.1.5 Boehringer Ingelheim Latest Developments
13.2 Ceva Sante Animale
13.2.1 Ceva Sante Animale Company Information
13.2.2 Ceva Sante Animale Pet Meds and Supplements Product Offered
13.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Ceva Sante Animale Main Business Overview
13.2.5 Ceva Sante Animale Latest Developments
13.3 Bimeda Animal Health
13.3.1 Bimeda Animal Health Company Information
13.3.2 Bimeda Animal Health Pet Meds and Supplements Product Offered
13.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Bimeda Animal Health Main Business Overview
13.3.5 Bimeda Animal Health Latest Developments
13.4 Dechra Pharmaceuticals
13.4.1 Dechra Pharmaceuticals Company Information
13.4.2 Dechra Pharmaceuticals Pet Meds and Supplements Product Offered
13.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Dechra Pharmaceuticals Main Business Overview
13.4.5 Dechra Pharmaceuticals Latest Developments
13.5 Zoetis
13.5.1 Zoetis Company Information
13.5.2 Zoetis Pet Meds and Supplements Product Offered
13.5.3 Zoetis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Zoetis Main Business Overview
13.5.5 Zoetis Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck Pet Meds and Supplements Product Offered
13.6.3 Merck Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Elanco
13.7.1 Elanco Company Information
13.7.2 Elanco Pet Meds and Supplements Product Offered
13.7.3 Elanco Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Elanco Main Business Overview
13.7.5 Elanco Latest Developments
13.8 Bayer
13.8.1 Bayer Company Information
13.8.2 Bayer Pet Meds and Supplements Product Offered
13.8.3 Bayer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer Main Business Overview
13.8.5 Bayer Latest Developments
13.9 Boehringer
13.9.1 Boehringer Company Information
13.9.2 Boehringer Pet Meds and Supplements Product Offered
13.9.3 Boehringer Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Boehringer Main Business Overview
13.9.5 Boehringer Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Pet Meds and Supplements Product Offered
13.10.3 Novartis Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
13.11 Virbac
13.11.1 Virbac Company Information
13.11.2 Virbac Pet Meds and Supplements Product Offered
13.11.3 Virbac Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Virbac Main Business Overview
13.11.5 Virbac Latest Developments
13.12 Ceva
13.12.1 Ceva Company Information
13.12.2 Ceva Pet Meds and Supplements Product Offered
13.12.3 Ceva Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Ceva Main Business Overview
13.12.5 Ceva Latest Developments
13.13 Vetoquinol
13.13.1 Vetoquinol Company Information
13.13.2 Vetoquinol Pet Meds and Supplements Product Offered
13.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Vetoquinol Main Business Overview
13.13.5 Vetoquinol Latest Developments
13.14 Nexvet
13.14.1 Nexvet Company Information
13.14.2 Nexvet Pet Meds and Supplements Product Offered
13.14.3 Nexvet Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Nexvet Main Business Overview
13.14.5 Nexvet Latest Developments
13.15 Aratana Therapeutics
13.15.1 Aratana Therapeutics Company Information
13.15.2 Aratana Therapeutics Pet Meds and Supplements Product Offered
13.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Aratana Therapeutics Main Business Overview
13.15.5 Aratana Therapeutics Latest Developments
13.16 Kindred Biosciences
13.16.1 Kindred Biosciences Company Information
13.16.2 Kindred Biosciences Pet Meds and Supplements Product Offered
13.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Kindred Biosciences Main Business Overview
13.16.5 Kindred Biosciences Latest Developments
13.17 Ambrx
13.17.1 Ambrx Company Information
13.17.2 Ambrx Pet Meds and Supplements Product Offered
13.17.3 Ambrx Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Ambrx Main Business Overview
13.17.5 Ambrx Latest Developments
13.18 Entest Biomedical
13.18.1 Entest Biomedical Company Information
13.18.2 Entest Biomedical Pet Meds and Supplements Product Offered
13.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Entest Biomedical Main Business Overview
13.18.5 Entest Biomedical Latest Developments
13.19 Taconic Biosciences
13.19.1 Taconic Biosciences Company Information
13.19.2 Taconic Biosciences Pet Meds and Supplements Product Offered
13.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Taconic Biosciences Main Business Overview
13.19.5 Taconic Biosciences Latest Developments
13.20 Dechra Veterinary Products
13.20.1 Dechra Veterinary Products Company Information
13.20.2 Dechra Veterinary Products Pet Meds and Supplements Product Offered
13.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Dechra Veterinary Products Main Business Overview
13.20.5 Dechra Veterinary Products Latest Developments
13.21 Ouro Fino Saude
13.21.1 Ouro Fino Saude Company Information
13.21.2 Ouro Fino Saude Pet Meds and Supplements Product Offered
13.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Ouro Fino Saude Main Business Overview
13.21.5 Ouro Fino Saude Latest Developments
13.22 Norbrook
13.22.1 Norbrook Company Information
13.22.2 Norbrook Pet Meds and Supplements Product Offered
13.22.3 Norbrook Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Norbrook Main Business Overview
13.22.5 Norbrook Latest Developments
13.23 Frontline
13.23.1 Frontline Company Information
13.23.2 Frontline Pet Meds and Supplements Product Offered
13.23.3 Frontline Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Frontline Main Business Overview
13.23.5 Frontline Latest Developments
13.24 Zesty Paws
13.24.1 Zesty Paws Company Information
13.24.2 Zesty Paws Pet Meds and Supplements Product Offered
13.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Zesty Paws Main Business Overview
13.24.5 Zesty Paws Latest Developments
14 Research Findings and Conclusion
Table 1. Pet Meds and Supplements Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pet Meds and Supplements Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of External Use
Table 4. Major Players of Oral Use
Table 5. Global Pet Meds and Supplements Sales by Type (2017-2022) & (Units)
Table 6. Global Pet Meds and Supplements Sales Market Share by Type (2017-2022)
Table 7. Global Pet Meds and Supplements Revenue by Type (2017-2022) & ($ million)
Table 8. Global Pet Meds and Supplements Revenue Market Share by Type (2017-2022)
Table 9. Global Pet Meds and Supplements Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Pet Meds and Supplements Sales by Application (2017-2022) & (Units)
Table 11. Global Pet Meds and Supplements Sales Market Share by Application (2017-2022)
Table 12. Global Pet Meds and Supplements Revenue by Application (2017-2022)
Table 13. Global Pet Meds and Supplements Revenue Market Share by Application (2017-2022)
Table 14. Global Pet Meds and Supplements Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Pet Meds and Supplements Sales by Company (2020-2022) & (Units)
Table 16. Global Pet Meds and Supplements Sales Market Share by Company (2020-2022)
Table 17. Global Pet Meds and Supplements Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Pet Meds and Supplements Revenue Market Share by Company (2020-2022)
Table 19. Global Pet Meds and Supplements Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Pet Meds and Supplements Producing Area Distribution and Sales Area
Table 21. Players Pet Meds and Supplements Products Offered
Table 22. Pet Meds and Supplements Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pet Meds and Supplements Sales by Geographic Region (2017-2022) & (Units)
Table 26. Global Pet Meds and Supplements Sales Market Share Geographic Region (2017-2022)
Table 27. Global Pet Meds and Supplements Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Pet Meds and Supplements Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Pet Meds and Supplements Sales by Country/Region (2017-2022) & (Units)
Table 30. Global Pet Meds and Supplements Sales Market Share by Country/Region (2017-2022)
Table 31. Global Pet Meds and Supplements Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Pet Meds and Supplements Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Pet Meds and Supplements Sales by Country (2017-2022) & (Units)
Table 34. Americas Pet Meds and Supplements Sales Market Share by Country (2017-2022)
Table 35. Americas Pet Meds and Supplements Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Pet Meds and Supplements Revenue Market Share by Country (2017-2022)
Table 37. Americas Pet Meds and Supplements Sales by Type (2017-2022) & (Units)
Table 38. Americas Pet Meds and Supplements Sales Market Share by Type (2017-2022)
Table 39. Americas Pet Meds and Supplements Sales by Application (2017-2022) & (Units)
Table 40. Americas Pet Meds and Supplements Sales Market Share by Application (2017-2022)
Table 41. APAC Pet Meds and Supplements Sales by Region (2017-2022) & (Units)
Table 42. APAC Pet Meds and Supplements Sales Market Share by Region (2017-2022)
Table 43. APAC Pet Meds and Supplements Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Pet Meds and Supplements Revenue Market Share by Region (2017-2022)
Table 45. APAC Pet Meds and Supplements Sales by Type (2017-2022) & (Units)
Table 46. APAC Pet Meds and Supplements Sales Market Share by Type (2017-2022)
Table 47. APAC Pet Meds and Supplements Sales by Application (2017-2022) & (Units)
Table 48. APAC Pet Meds and Supplements Sales Market Share by Application (2017-2022)
Table 49. Europe Pet Meds and Supplements Sales by Country (2017-2022) & (Units)
Table 50. Europe Pet Meds and Supplements Sales Market Share by Country (2017-2022)
Table 51. Europe Pet Meds and Supplements Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Pet Meds and Supplements Revenue Market Share by Country (2017-2022)
Table 53. Europe Pet Meds and Supplements Sales by Type (2017-2022) & (Units)
Table 54. Europe Pet Meds and Supplements Sales Market Share by Type (2017-2022)
Table 55. Europe Pet Meds and Supplements Sales by Application (2017-2022) & (Units)
Table 56. Europe Pet Meds and Supplements Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Pet Meds and Supplements Sales by Country (2017-2022) & (Units)
Table 58. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Pet Meds and Supplements Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Pet Meds and Supplements Sales by Type (2017-2022) & (Units)
Table 62. Middle East & Africa Pet Meds and Supplements Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Pet Meds and Supplements Sales by Application (2017-2022) & (Units)
Table 64. Middle East & Africa Pet Meds and Supplements Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Pet Meds and Supplements
Table 66. Key Market Challenges & Risks of Pet Meds and Supplements
Table 67. Key Industry Trends of Pet Meds and Supplements
Table 68. Pet Meds and Supplements Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Pet Meds and Supplements Distributors List
Table 71. Pet Meds and Supplements Customer List
Table 72. Global Pet Meds and Supplements Sales Forecast by Region (2023-2028) & (Units)
Table 73. Global Pet Meds and Supplements Sales Market Forecast by Region
Table 74. Global Pet Meds and Supplements Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Pet Meds and Supplements Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Pet Meds and Supplements Sales Forecast by Country (2023-2028) & (Units)
Table 77. Americas Pet Meds and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Pet Meds and Supplements Sales Forecast by Region (2023-2028) & (Units)
Table 79. APAC Pet Meds and Supplements Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Pet Meds and Supplements Sales Forecast by Country (2023-2028) & (Units)
Table 81. Europe Pet Meds and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Pet Meds and Supplements Sales Forecast by Country (2023-2028) & (Units)
Table 83. Middle East & Africa Pet Meds and Supplements Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Pet Meds and Supplements Sales Forecast by Type (2023-2028) & (Units)
Table 85. Global Pet Meds and Supplements Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Pet Meds and Supplements Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Pet Meds and Supplements Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Pet Meds and Supplements Sales Forecast by Application (2023-2028) & (Units)
Table 89. Global Pet Meds and Supplements Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Pet Meds and Supplements Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Pet Meds and Supplements Revenue Market Share Forecast by Application (2023-2028)
Table 92. Boehringer Ingelheim Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 93. Boehringer Ingelheim Pet Meds and Supplements Product Offered
Table 94. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Boehringer Ingelheim Main Business
Table 96. Boehringer Ingelheim Latest Developments
Table 97. Ceva Sante Animale Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 98. Ceva Sante Animale Pet Meds and Supplements Product Offered
Table 99. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Ceva Sante Animale Main Business
Table 101. Ceva Sante Animale Latest Developments
Table 102. Bimeda Animal Health Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 103. Bimeda Animal Health Pet Meds and Supplements Product Offered
Table 104. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Bimeda Animal Health Main Business
Table 106. Bimeda Animal Health Latest Developments
Table 107. Dechra Pharmaceuticals Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 108. Dechra Pharmaceuticals Pet Meds and Supplements Product Offered
Table 109. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Dechra Pharmaceuticals Main Business
Table 111. Dechra Pharmaceuticals Latest Developments
Table 112. Zoetis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 113. Zoetis Pet Meds and Supplements Product Offered
Table 114. Zoetis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Zoetis Main Business
Table 116. Zoetis Latest Developments
Table 117. Merck Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 118. Merck Pet Meds and Supplements Product Offered
Table 119. Merck Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Merck Main Business
Table 121. Merck Latest Developments
Table 122. Elanco Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 123. Elanco Pet Meds and Supplements Product Offered
Table 124. Elanco Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Elanco Main Business
Table 126. Elanco Latest Developments
Table 127. Bayer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 128. Bayer Pet Meds and Supplements Product Offered
Table 129. Bayer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Bayer Main Business
Table 131. Bayer Latest Developments
Table 132. Boehringer Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 133. Boehringer Pet Meds and Supplements Product Offered
Table 134. Boehringer Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Boehringer Main Business
Table 136. Boehringer Latest Developments
Table 137. Novartis Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 138. Novartis Pet Meds and Supplements Product Offered
Table 139. Novartis Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Novartis Main Business
Table 141. Novartis Latest Developments
Table 142. Virbac Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 143. Virbac Pet Meds and Supplements Product Offered
Table 144. Virbac Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Virbac Main Business
Table 146. Virbac Latest Developments
Table 147. Ceva Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 148. Ceva Pet Meds and Supplements Product Offered
Table 149. Ceva Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Ceva Main Business
Table 151. Ceva Latest Developments
Table 152. Vetoquinol Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 153. Vetoquinol Pet Meds and Supplements Product Offered
Table 154. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Vetoquinol Main Business
Table 156. Vetoquinol Latest Developments
Table 157. Nexvet Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 158. Nexvet Pet Meds and Supplements Product Offered
Table 159. Nexvet Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Nexvet Main Business
Table 161. Nexvet Latest Developments
Table 162. Aratana Therapeutics Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 163. Aratana Therapeutics Pet Meds and Supplements Product Offered
Table 164. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Aratana Therapeutics Main Business
Table 166. Aratana Therapeutics Latest Developments
Table 167. Kindred Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 168. Kindred Biosciences Pet Meds and Supplements Product Offered
Table 169. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Kindred Biosciences Main Business
Table 171. Kindred Biosciences Latest Developments
Table 172. Ambrx Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 173. Ambrx Pet Meds and Supplements Product Offered
Table 174. Ambrx Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Ambrx Main Business
Table 176. Ambrx Latest Developments
Table 177. Entest Biomedical Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 178. Entest Biomedical Pet Meds and Supplements Product Offered
Table 179. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Entest Biomedical Main Business
Table 181. Entest Biomedical Latest Developments
Table 182. Taconic Biosciences Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 183. Taconic Biosciences Pet Meds and Supplements Product Offered
Table 184. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Taconic Biosciences Main Business
Table 186. Taconic Biosciences Latest Developments
Table 187. Dechra Veterinary Products Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 188. Dechra Veterinary Products Pet Meds and Supplements Product Offered
Table 189. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Dechra Veterinary Products Main Business
Table 191. Dechra Veterinary Products Latest Developments
Table 192. Ouro Fino Saude Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 193. Ouro Fino Saude Pet Meds and Supplements Product Offered
Table 194. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. Ouro Fino Saude Main Business
Table 196. Ouro Fino Saude Latest Developments
Table 197. Norbrook Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 198. Norbrook Pet Meds and Supplements Product Offered
Table 199. Norbrook Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 200. Norbrook Main Business
Table 201. Norbrook Latest Developments
Table 202. Frontline Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 203. Frontline Pet Meds and Supplements Product Offered
Table 204. Frontline Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 205. Frontline Main Business
Table 206. Frontline Latest Developments
Table 207. Zesty Paws Basic Information, Pet Meds and Supplements Manufacturing Base, Sales Area and Its Competitors
Table 208. Zesty Paws Pet Meds and Supplements Product Offered
Table 209. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 210. Zesty Paws Main Business
Table 211. Zesty Paws Latest Developments
List of Figures
Figure 1. Picture of Pet Meds and Supplements
Figure 2. Pet Meds and Supplements Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pet Meds and Supplements Sales Growth Rate 2017-2028 (Units)
Figure 7. Global Pet Meds and Supplements Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pet Meds and Supplements Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of External Use
Figure 10. Product Picture of Oral Use
Figure 11. Global Pet Meds and Supplements Sales Market Share by Type in 2021
Figure 12. Global Pet Meds and Supplements Revenue Market Share by Type (2017-2022)
Figure 13. Pet Meds and Supplements Consumed in Dogs
Figure 14. Global Pet Meds and Supplements Market: Dogs (2017-2022) & (Units)
Figure 15. Pet Meds and Supplements Consumed in Cats
Figure 16. Global Pet Meds and Supplements Market: Cats (2017-2022) & (Units)
Figure 17. Pet Meds and Supplements Consumed in Rabbit
Figure 18. Global Pet Meds and Supplements Market: Rabbit (2017-2022) & (Units)
Figure 19. Pet Meds and Supplements Consumed in Bird
Figure 20. Global Pet Meds and Supplements Market: Bird (2017-2022) & (Units)
Figure 21. Pet Meds and Supplements Consumed in Other
Figure 22. Global Pet Meds and Supplements Market: Other (2017-2022) & (Units)
Figure 23. Global Pet Meds and Supplements Sales Market Share by Application (2017-2022)
Figure 24. Global Pet Meds and Supplements Revenue Market Share by Application in 2021
Figure 25. Pet Meds and Supplements Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Pet Meds and Supplements Revenue Market Share by Company in 2021
Figure 27. Global Pet Meds and Supplements Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Pet Meds and Supplements Revenue Market Share by Geographic Region in 2021
Figure 29. Global Pet Meds and Supplements Sales Market Share by Region (2017-2022)
Figure 30. Global Pet Meds and Supplements Revenue Market Share by Country/Region in 2021
Figure 31. Americas Pet Meds and Supplements Sales 2017-2022 (Units)
Figure 32. Americas Pet Meds and Supplements Revenue 2017-2022 ($ Millions)
Figure 33. APAC Pet Meds and Supplements Sales 2017-2022 (Units)
Figure 34. APAC Pet Meds and Supplements Revenue 2017-2022 ($ Millions)
Figure 35. Europe Pet Meds and Supplements Sales 2017-2022 (Units)
Figure 36. Europe Pet Meds and Supplements Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Pet Meds and Supplements Sales 2017-2022 (Units)
Figure 38. Middle East & Africa Pet Meds and Supplements Revenue 2017-2022 ($ Millions)
Figure 39. Americas Pet Meds and Supplements Sales Market Share by Country in 2021
Figure 40. Americas Pet Meds and Supplements Revenue Market Share by Country in 2021
Figure 41. United States Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Pet Meds and Supplements Sales Market Share by Region in 2021
Figure 46. APAC Pet Meds and Supplements Revenue Market Share by Regions in 2021
Figure 47. China Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Pet Meds and Supplements Sales Market Share by Country in 2021
Figure 54. Europe Pet Meds and Supplements Revenue Market Share by Country in 2021
Figure 55. Germany Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country in 2021
Figure 62. Egypt Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Pet Meds and Supplements Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Pet Meds and Supplements in 2021
Figure 68. Manufacturing Process Analysis of Pet Meds and Supplements
Figure 69. Industry Chain Structure of Pet Meds and Supplements
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...